Series E - RedShift BioAnalytics
Investment Firm
Overview
RedShift BioAnalytics is a developer and manufacturer of bioanalytical tools for the life science market.
Announced Date
Oct 18, 2021
Funding Type
Series E
Highlights
Location
United States, North America
Social
Participant Investors
3
Round Details and Background
RedShift BioAnalytics raised $20000000 on 2021-10-18 in Series E
RedShift BioAnalytics is a developer and manufacturer of bioanalytical tools for the life science market.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 02, 2015 |  Venture Round - RedShift BioAnalytics | - | 998.1K | |
| Apr 03, 2014 | Venture Round - RedShift BioAnalytics | - | 751.5K | |
| Apr 11, 2013 | Series B - RedShift BioAnalytics | 1 | - | 3.0M |
| Jan 12, 2006 | Series A - RedShift BioAnalytics | 6 | - | 12.0M |
Recent Activity
There is no recent news or activity for this profile.